The breach occurred as part of a ransomware attack against service provider Blackbaud. Inova Health Systems has notified customers that it was hit by a ransomware attack through a third-party vendor. Blackbaud, a vendor that provides fundraising support to nonprofit organizations, was itself hit by an attack that resulted in Inova data being exfiltrated from the Blackbaud servers. Related Content:
According to Blackbaud, data was exfiltrated between February 7, 2020, and May 20, 2020. The exfiltration was part of a ransomware attack that did not succeed in encrypting significant data at Blackbaud. Ultimately, though, the company says that it paid a ransom in order to have the exfiltrated data destroyed, which it says was done. The exfiltrated data included personally identifiable information on patients and donors to Inova, though it did not include Social Security numbers or payment information. Blackbaud says that it has remediated the vulnerability that allowed the attack, and that its data is now safe. For more, read here . Dark Reading's Quick Hits delivers a brief synopsis and summary of the significance of breaking news events. For more information from the original source of the news item, please follow the link provided in this article. View Full Bio

Inova Health Systems Hit by Third-Party Data Breach

Inova Suffers Third-Party Data Breach

St. Louis, Missouri, October 28, 2019  / BusinessWire / – PierianDx , the leading clinical genomics informatics company, today announced that it has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures that also includes existing investors Health Catalyst Capital, Inova Health Systems, RTI International, and ARUP Laboratories. PierianDx provides a SaaS platform that enables the practice of clinical genomics as a standard of care and empowers the world’s most advanced molecular diagnostic labs. Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Dr. Rakesh Nagarajan, Founder and Executive Chairman of PierianDx, said, “PierianDx has grown tremendously over the past 18 months and is continuing to add the clinical expertise and resources necessary to execute on our vision. Our team is uniquely skilled and dedicated to the adoption of clinical NGS around the globe.”
Michael L. Sanderson, CEO of PierianDx, said, “Our new capital infusion will accelerate the commercial expansion of PierianDx’s leading clinical genomics platform in the U.S. and global markets throughout Europe, Asia, Australia, Latin America, and North America, as we continue to work with leading sequencer, assay and pharma partners in our explosive space. PierianDx is fueled by making the most advanced clinically actionable cancer care accessible to everyone, regardless of location or ability to pay.”
“We are excited about leading the Series B investment in PierianDx. We believe PierianDx will change the way cancer is treated worldwide and we are proud to be investors,” said Mr. Kerry Propper, Co-Founder and Managing Partner of ATW Partners. About PierianDx
At PierianDx, we empower progressive health institutions and diagnostic laboratories to build world-class precision medicine programs. Our industry-leading clinical genomics technologies, CAP and CLIA accredited laboratory, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, we drive the adoption of genomics in clinical care and accelerate the fight against cancer and other diseases. www.pieriandx.com

SJF Co-Leads PierianDx Series B

Share
Sanofi and Innovation Health — an insurance company jointly run by Inova and Aetna —have announced a pilot program examining the impact of digital health strategies to improve care for Type 2 diabetes patients. The program will tap One Drop , a diabetes self-management app and Bluetooth blood sugar monitor, and Gocap , a mobile-friendly device and insulin dose management platform that emphasizes physician involvement, in an effort to improve medication adherence and patient outcomes. "We've always put a priority on finding innovative ways to reach consumers,” Dr. Sunil Budhrani, chief medical officer and chief medical informatics officer at Innovation Health, told MobiHealthNews. “Consumers with Type 2 diabetes face unique health challenges that could be improved through technologies like these that encourage closer communication with physicians and understanding a patients unique health needs. With this pilot program we're excited to see how new technologies impact outcomes for Type 2 diabetes patients." The pilot program itself will be facilitated by Innovation Health, Inova Health Systems, and Aetna’s Healthagen division. Specifically, Budhrani noted that the program will show how new technologies can help improve public health. Sebastien Coisne, vice president of Innovative Solutions at Sanofi, said that the platforms could also ease the burden of self-management for beleaguered patients. “Our ambition is to empower people with diabetes to live the life they want,” Coisne said in a statement. “We believe that combining innovative medicines with connected devices and solutions leads to better patient outcomes and an improved patient experience.”
New York-based One Drop’s self-management platform has been around for a few years, but recently saw an increased focus on user accessibility. Along with its 24-7 access to coaches through a real-time, in-app chat, the service expanded its subscription program and added Amazon Alexa integration in June. “Accessibility is a foundational value at One Drop,” CEO and founder Jeff Dachis said in a statement at the time. “With new voice and alternative visual interfaces, we are extending our commitment to accessible care with features and programs that allow access to data-driven diabetes care for those with vision challenges, advanced neuropathy, or limited dexterity/mobility, the elderly, caregivers, as well as those challenged by the visual/tactile interfaces associated with smartphones.”
Cambridge, Massachusetts-based Common Sensing ’s Gocap is an insulin pen cap that automatically logs usage data to an app once placed on the pen. This data can be easily provided to physicians for more accurate feedback on whether or not the patient is using their insulin correctly or if there is an issue with treatment. Common Sensing launched a clinical trial of the platform last October in collaboration with Joslin Diabetes Center, Sanofi, and Dexcom, and as of that time had raised $5 million in funding from Qualcomm, Sanofi, and Waterline Ventures. There are also a number of diabetes management apps currently available for download, many of which MobiHealthNews covered in its 2017 roundup of options available on Apple’s store. Tags:

Sanofi, Aetna-Inova JV target diabetes with digital therapeutic pilot program

Inova Translational Medicine Institute Receives $9.5 Million Award from NIH
10/3/16
Inova Health System today announced that the Inova Translational Medicine Institute (ITMI) has been awarded a $9.5 million grant from the National Institutes of Health (NIH) to study environmental influences on child health. The Icahn School of Medicine at Mount Sinai Medical Center, New York City is the primary recipient of the consortium award. John Niederhuber, MD, CEO, ITMI, is principle investigator for the ECHO sub-award to ITMI. Announced September 21 by NIH, this grant is part of a series of awards launching a seven-year research initiative titled the Environmental Influences on Child Health Outcomes (ECHO) . These awards, given to a variety of centers across the country, including ITMI, will investigate how exposure to environmental factors and maternal behavior – from pre-conception, through gestation and early childhood – impact health and development of babies through early childhood and into adolescent years. The ECHO environmental studies will include exposures to air pollution, chemicals in homes, neighborhoods and work places, stress, and individual behaviors such as sleep and diet, and relate these factors to genomic changes and clinical outcomes in the newborn. The ECHO program will help support and greatly expand the utilization of a number of synergistic existing childhood longitudinal cohort studies at different sites, including ITMI's Childhood Longitudinal Cohort Study, which began accrual in July 2012. "I am extremely excited to be part of this national effort to better understand how we as individuals, the life choices we make, and our environment impact our development as newborns and our future wellness," said Dr. Niederhuber. "This was my vision when I came to Inova and initiated the Childhood Longitudinal Cohort. If you want to understand behavior, neurologic development and the earliest stages of progression toward disease, then you must start at the beginning. "
Dr. Niederhuber has led the ongoing collaborations with the Mount Sinai team since 2014 and serves as the Principle Investigator for the ECHO sub-award to ITMI. Other partners in the Mt. Sinai consortium ECHO award include Harvard, Ben Gurion University, Columbia University, the University of North Carolina and Northwestern University. Of this group, ITMI has the largest cohort of families and newborns being actively followed, with over 3000 families enrolled over the past four years. The grant award greatly expands the research efforts of the existing ITMI cohort. About Inova
Inova is a not-for-profit healthcare system based in Northern Virginia that serves more than 2 million people each year throughout the Washington, DC, metro area and beyond. Inova is a comprehensive network of hospitals, outpatient services and facilities, primary and specialty care practices, and health and wellness initiatives.


Inova Translational Medicine Institute Receives $9.5 Million Award from NIH

Somatus aims to delay or prevent the progression of chronic kidney disease (CKD) to ESRD, help eligible patients access home-based dialysis modalities which improve their outcomes, and maximize the number of patients who qualify for and receive kidney transplantation. Users can receive concierge kidney care in the comfort of your home. As a patient, they will have direct access to 24/7 medical attention. Somatus' team will be comprised of nurses, physicians, and other health professionals who can anticipate as well as address medical needs.

Somatus

MCLEAN , Va. , March 9 , 2023 / PRNewswire / -- Somatus , the nation 's leading and largest value-based kidney care company , and Inova announce the new Nurse Navigator Program launch , an innovative addition to the already successful partnership .

10:00 ET
Somatus Expands Partnership with Inova to Further Enhance Care and Improve Outcomes for Patients

D.C. United are an American professional soccer team based in Washington, D.C. that competes in Major League Soccer (MLS).

D.C. United

D.C. United marks the fourth professional sports team to partner with Inova , the release said .

Inova Sports Medicine partners with Major League Soccer club

CipherHealth helps hospitals avoid government penalties by reducing preventable readmissions, improving outcomes, better coordinating care, and creating a positive patient experience. CipherHealth reaches out over the phone, through tablets, via email, text, or the web, better engaging patients in their care and building stronger relationships between patients and providers. The company was formed through a partnership of New York eHealth Collaborative and Partnership Fund for New York City.

CipherHealth

In November 2021 , CipherHealth partner Inova Health , Northern Virginia 's largest health system , kicked off its executive rounding program .

How Inova Supports Its Frontline Teams: Executive Rounding - Cipherhealth

Select Medical engages in the provision of medical rehabilitation services. It operates through the following segments: Specialty Hospitals, Outpatient Rehabilitation, and Concentra. The Specialty Hospitals segment involves in providing long term acute care hospital services and inpatient acute rehabilitative hospital care. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which delivers occupational medicine, physical therapy, veteran's healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in October 2004 and is headquartered in Mechanicsburg, PA.

Select Medical

George Mason University specializes in various education degrees such as telecommunications, cybersecurity, big data, healthcare technology, robotics, and autonomous systems, signals and communications, sustainable infrastructure, engineering, mechanical engineering, bioengineering, data analytics, computer science, and electrical and computer engineering. It is based in Fairfax, Virginia.

George Mason University

Inova Health Systems

Anthem

Deerfield Management

Fidelity Investments

Flare Capital Partners

Longitude Capital

Optum Ventures

RA Capital Management

The Blue Venture Fund

Wellington Management

Grant - II

Inova is a not-for-profit healthcare system based in Northern Virginia that serves more than two million people each year from throughout the Washington, DC, metro area and beyond. Governed by a volunteer board of community members, Inova has grown from one hospital in 1956 to a nationally recognized, comprehensive network of hospitals, outpatient services and facilities, primary and specialty care physician practices, and health and wellness initiatives serving the Washington, DC, metro area.

Wells Fargo Success Story

Professional Services

Platform Overview

Inova Health Systems

Inova Health Systems’s Customers

Compete with Inova Health Systems?

Compete with Inova Health Systems?

Discover the right solution for your team